Abstract
Introduction
The normal response to blood vessel injury involves platelet activation and triggering of the soluble blood clotting system, which together result in the formation of a stabilized haemostatic plug in order to minimize further blood loss. Clotting is typically initiated when the cell-surface protein, tissue factor, is exposed to plasma factor VIIa following vessel injury [1] . [2] . Because DIC contributes to the multi-system organ failure accompanying fatal septicaemia [3, 4] several anticoagulant and pro-fibrinolytic agents have been investigated as treatments for severe sepsis. The therapeutic value of such drugs in phase 3 clinical trials proved inconclusive [5] [6] [7] until the PROWESS trial in 2001 demonstrated the efficacy of activated protein C (aPC) for this purpose [8] . Perhaps not coincidentally, the therapeutic function of aPC is thought to arise, at least in part, from its anti-inflammatory properties [9] 
Inorganic polyP in nature
PolyP is a linear polymer of inorganic phosphate linked via high energy phosphoanhydride bonds, which can range in size from just a few to over a thousand phosphate units long [10, 11] . PolyP is ubiquitous in nature, being found in all taxonomic kingdoms of life and possibly even predating life itself [10] . PolyP has mainly been studied in unicellular prokaryotes and eukaryotes, with much less known about its roles in higher organisms. For example, the only eukaryote with an identified polyP kinase is the cellular slime mould, Dictyostelium discoideum [12] . The development of newer polyP detection assays has spurred recent research into the possible functions of polyP in vertebrates, leading to proposed roles in cancer, cell proliferation [13] , angiogenesis [14] , osteoblast function [15] and apoptosis [16] .
In [17] . Like acidocalcisomes, platelet dense granules are spherical, acidic [18] , electron dense [19] and have high concentrations of divalent cations and pyrophosphate [20] . Ruiz et al. reported that platelet dense granules contain abundant polyP, and furthermore that platelets secrete polyP following thrombin stimulation [17] . We recently showed that polyP asserts considerable procoagulant and anti-fibrinolytic effects [21] [22] [23] . This raises the possibility that polyP may contribute to consumptive coagulopathies accompanying bacterial sepsis, since polyP can accumulate to abundance in microorganisms. [24] , in the absence of thrombin [25] and at physiological concentrations of clotting factors [26] . However, we speculate that polyP's ability to enhance the factor Xa/factor V interaction might offset this deficiency and allow factor Xa to contribute to factor V activation in vivo.
PolyP modulates haemostasis
Accelerating the rate of factor V activation by polyP results in an earlier thrombin burst and has interesting consequences for regulatory reactions in the blood clotting system [21] . For example, adding polyP to plasma abrogates the anticoagulant function of tissue factor pathway inhibitor (TFPI), a plasma serine protease inhibitor that is considered to be the major inhibitor of the initiation phase of blood clotting [27] . Studies have demonstrated that factor Xa is protected from inhibition by TFPI in the presence of both its cofactor (factor Va) and its natural substrate, prothrombin [21, 28] . Although the exact mechanism is unknown, prothrombin likely competes with TFPI for a binding site on factor Xa within the prothrombinase complex. In studies by our group, polyP abolished the anticoagulant action of TFPI in clotting reactions in which exogenous TFPI was added to plasma [21] . This effect of polyP was not observed when the same proteins were combined in a plasma-free system, suggesting an additional plasma component such as factor V was needed for TFPI functional inactivation.
PolyP alters fibrin clot structure and stability
We also showed that the presence of polyP in clotting reactions alters the physical structure of fibrin clots, generating thicker fibrin fibrils that are more resistant to fibrinolysis than are clots formed in the absence of polyP [23] [30, 31] . These observations would suggest that polyP affects clot structure in a unique way that is not recapitulated by heparin or other anionic polymers that have been tested [32] . 
Degradation of polyP in plasma

Omptin structure
Omptins are a family of outer membrane proteases expressed in Gram-negative bacteria that share about 40 to 50% sequence homology. They are composed of 10-antiparallel strands which form a vase-shaped barrel embedded in the outer membrane [57] . Comprising the rim of this vase are five surface exposed loops which confer much of the substrate specificity of the various omptins [58] [60, 63] . [52] . Pla expression increases virulence in animal models of pneumonic plague although not to the extent seen in bubonic plague models [71] .
. The active site cleft is formed just beneath the rim of this 'vase' and is composed of two opposing pairs of catalytic residues, a His-Asp dyad resembling the serine protease HisAsp-Ser triad and an Asp-Asp dyad resembling the active site of aspartyl proteases. Mechanistically, it is thought that the His-Asp dyad activates a water molecule for nucleophilic attack on the substrate's scissile bond [59], while the Asp-Asp dyad has been proposed to participate in catalysis by proton translocation or stabilization of the oxyanion intermediate (reviewed by Haiko et al. [60]). OmpT in E. coli exhibits a preference for cleaving substrates between consecutive basic residues [61, 62]; since the aforementioned catalytic residues are conserved in all omptins, it is assumed that Pla displays a similar substrate preference. LPS is required for the enzymatic activity of omptins, and in particular, LPS with short O-antigen side chains (rough LPS) is required for omptin activity toward many exogenous macromolecular substrates [63, 64]. It is thought that an extended O-antigen side chain (smooth LPS) sterically interferes with substrate binding [65], a significant observation since Y. pestis is one of the few omptin-expressing bacteria that naturally express rough LPS. Indeed, the evolution of Pla's activity toward foreign substrates may have been a major determinant in eliminating O-antigen expression in Y. pestis
Evolution of Y. pestis and its life cycle
Expression of Pla increases Y. pestis virulence
The virulence role of Pla is intimately tied to the bubonic (and pneumonic) forms of the disease, since expression of Pla has no significance in infectivity or lethality when the pathogen is introduced intravascularly
These two experimental findings give our first clue to the functional role of Pla in Y. pestis virulence, namely that Pla must act in an extravascular setting. The exact mechanism(s) by which Pla exerts its effects is not completely understood, as most studies using bubonic plague models have focused on morphological alterations in the host or differences in bacterial or inflammatory cell counts as a result of Pla expression [52-55]. These findings can be generalized as follows: (1) Pla expression results in attenuated inflammatory cell recruitment (particularly neutrophils) to infected lesions; (2) Pla expression causes a structural derangement of infected lymph tissue characterized by lymphadenitis, necrosis, haemorrhage, thrombosis and disorganized masses of infiltrating bacteria and (3) Pla expression promotes the systemic dissemination of the infection.
Animal studies also show that the number of Y. pestis bacteria localized to subcutaneous injection sites is not altered by Pla expression [52, 54] [52, 54] [54] , even though they may subsequently infect other organs such as the liver and spleen and result in mortality to the host [55] . Guinet et al. [73] 
, indicating that Pla exerts its effects after initial colonization in the dermis but before systemic infiltration of the vasculature. What is altered, however, is the extent of the host inflammatory response in infected draining lymph nodes as the number of inflammatory cells is greatly reduced upon expression of Pla
also noted that rat lymph nodes infected by Pla-deficient Y. pseudotuberculosis retained their general architecture, along with abscess-type polymorphonuclear infiltrates which sequestered the infection. This happened even though the bacterial count in the lymph node 24 hrs after infection was similar to the count in Y. pestis infections. These results argue that the evolution of Pla facilitates the bubonic form of Y. pestis infection, exerting its virulence function mainly within the context of a regional draining lymph node. This is not surprising, as infection of the bubo can be considered a bottleneck in the systemic spread of the disease. It is at this stage of the infection where Y. pestis first multiply in great numbers
Plasminogen activation by Pla
The ability of Pla to promote systemic dissemination has been attributed to its ability to generate plasmin, an enzyme that can promote general proteolysis, and also to the ability of Pla to inactivate the main physiological inhibitor of plasmin, ␣2-antiplasmin [58] . Pla has been shown to proteolytically activate human Gluplasminogen to plasmin with a kcat of 0.21/min. [52] . For comparison, urokinase-type plasminogen activator converts plasminogen to plasmin with a kcat of 89/min. [74] . Plasmin is rather promiscuous in its substrate recognition, and has been shown to degrade extracellular matrix components, activate procollagenases, inactivate collagenase inhibitors and promote cell migration [75] [76] [77] . Lathem et al. observed [82] . Pla is also thought to act as an adhesin to mammalian basement membranes by binding laminin [83] and expression of Pla was also found to be critical for the invasion of HeLa cells by Y. pestis [84] . How these other potential functions of Pla aid Y. pestis in its ability to generate bubonic infections will undoubtedly be a focus of much future research.
